Sacral nerve stimulation: Interstim® therapy

Expert Review of Medical Devices

Volumn 2, Issue 3, 2005, Pages 253-258

  Peeren, Frederick ^a   Hoebeke, Piet ^a   Everaert, Karel ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic voiding dysfunction; Incontinence; Neuron; Pelvic floor dysfunction; Sacral nerve stimulation

Indexed keywords

DEVICE; ELECTROSTIMULATION; INTERSTITIAL CYSTITIS; MICTURITION DISORDER; MICTURITION REFLEX; NERVE FIBER C; NERVE STIMULATION; NEUROANATOMY; NEUROMODULATION; NEUROPATHIC PAIN; PELVIS FLOOR; PELVIS PAIN SYNDROME; PUDENDAL NERVE; REVIEW; SACRAL SPINAL CORD; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; URGE INCONTINENCE;

EID: 18844403646     PISSN: 17434440     EISSN: None     Source Type: Journal    
DOI: 10.1586/17434440.2.3.253     Document Type: Review

References (48)

1. Tanagho EA, Schmidt RA. Clinical significance of sacral and pudendal nerve anatomy. J Urol. 140, 1331 (1988).
2. Schmidt RA, Jonas U, Oleson K et al. Sacral nerve stimulation for the treatment of refractory urinary urge incontinence. J. Urol. 162, 352-357 (1990).
3. Jonas U, Fowler CJ, Chancellor MB et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J. Urol. 165, 15-19 (2001).
4. Chancellor MB, Leng W. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 17-28 (2002).
5. Grünewald V, Höfner K. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 202, 69 (2003).
6. Grünewald V, Jonas U. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 117 (2002).
7. Abrams P, Blaivas JG, Fowler CJ et al. The role of neuromodulation in the management of urinary urge incontinence. Br. J. Urol. Int. 91, 355-359 (2003).
8. Scheepens WA, van Kerrebroeck PEV. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 202, 89 (2003).
9. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol. Urodyn. 21, 167-178 (2002).
10. Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology 60(5 Suppl. 1) 7-12 (2002).
11. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br. J. Urol. Int. 87, 760-766 (2001).
12. Fantl JA, Newman DK, Colling J et al. Urinary incontinence in adults: acute and chronic management clinical Practice Guideline. No. 2, 1996 Update. In: Public Health Service Pulications. Agency for Healthcare policy and Reasearch (AHCPR) MD, USA 96-0682 (1996).
13. DasGupta R, Fowler CJ. The management of female voiding dysfunction: Fowler's syndrome - a contemporary update. Curr. Opin. Urol. 13, 293-299 (2003).
14. Swinn M, Kitchen N, Goodwin R, Fowler C. Sacral neuromodulation for women with Fowler's syndrome. Eur. Urol. 38, 439-443 (2000).
15. van Kerrebroeck P, van Voskuilen A, Lycklama A et al. Eur. Urol. (Suppl. 3), 170 (2004).
16. van Voskuilen A, van Kerrebroeck P,Dijkema H et al. J. Urol. 171(Suppl. 3), 28 (2004).
17. Everaert K. Interstim® therapy as good treatment option for pelvic floor dysfunctions. Medtronic workshop - August 25, 2004.
18. Emerging indications for SNS. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 19, 223-240 (2002).
19. Bosch JLHR, Chartier-Kastler EJ. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 202, 224-226.
20. Gillenwaterwater JY, Wein AJ. Summary of the National institute of Arthrtis, Diabetes, Digestive and Kidney diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, USA August 28-29, 1987. J. Urol. 140, 203-206 (1988).
21. Chai TC. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 202, 228 (2003).
22. Chai TC, Zhang C, Warren JW, Keay S. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 55, 643-646 (2000).
23. Everaert K, Peeren F. In: New Perspectives in Sacral Nerve Stimulation. Martin Dunitz Ltd. London, UK, 202, 229-232 (2003).
24. Stones RW, Selfe SA, Fransman S, Horn SA. Psychosocial and economic impact of chronic pelvic pain. Baillieres Clin. Obstet. Gynaecol. 14, 415-431 (2000).
25. Nickel JC, Nigro M, Valiquette L et al.. Diagnosis and Treatment of prostatitis in Canada. Urology 52, 797-802 (1998).
26. Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA. Neurourological insights into the etiology of genitourinary pain in men. J. Urol. 161, 903-908 (1999).
27. Birklein F, Weber M, Ernst M. et al. Increased skin lactate in complex regional pain syndrome: evidence for tissue hypoxia? Pain 87, 227-234 (2000).
28. Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. J. Am. Med. Assoc. 274, 559-561 (1995).
29. Matzel KE, Kamm MA, Stösser MS et al. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet 363, 1270-1276 (2004).
30. Kenefick NJ, Nicholls RJ, Cohen RG, Kamm MA. Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br. J. Surg. 89, 882-888 (2002).
31. Malouf AJ, Wiesel PH, Nicholls T et al. Short-term effects of sacral nerve stimulation for idiopathic slow transit constipation. World J. Surg. 26, 166-170 (2002).
32. Everaert K, Kerckhaert W, Caluwaert H et al. A prospective randomized trial comparing the one-stage with the two-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur. Urol. 45(5), 649-654 (2004).
33. Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 49(3), 358-362 (1997).
34. Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and fast experience. J. Urol. 170(5), 1905-1907 (2003).
35. Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J. Urol. 172(4 Pt. 2), 1673-1676 (2004).
36. Scheepens WA, Weil EH, van Koeveringe GA et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation-a multicenter study. Eur. Urol. 40(4), 434-438 (2001).
37. Malaguti S, Spinelli M, Giardiello G, Lazzeri M, Van Den Hombergh U. Neurophysiological evidence may predict the outcome of sacral neuromodulation. J. Urol. 170(6 Pt. 1), 2323-2326 (2003).
38. Tai C, Roppolo JR, de Groat WC. Block of external urethral sphincter contraction by high frequency electrical stimulation of pudendal nerve. J. Urol. 172(5 Pt. 1), 2069-2072 (2004).
39. Van Balken MR, Vergunst H, Bemelmans BL. The use of electrical devices for the treatment of bladder dysfunction: a review of methods. J. Urol. 172(3), 846-851 (2004).
40. Abrams P, Blaivas JG, Fowler CJ et al. The role of neuromodulation in the management of urinary urge incontinence. Brit. J. Urol. Int. 91, 355-359 (2003).
41. Schultz-Lampel D, Jiang C, Lindstrom S, Thuroff JW. Experimental results on mechanisms of action of electrical neuromodulation in chronic urinary retention. World J. Urol. 16(5), 301-304 (1998).
42. Leng WW, Chancellor MB. How sacral neuromodulaton works. Urol. Clin. North Am. 32(1), 11-18 (2005).
43. Fowler CJ, Swinn MJ, Goodwin RJ, Oliver S, Craggs M. Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated. J. Urol. 163(3), 881-883 (2000).
44. Scheepens WA, Van Koeveringe GA, De Bie RA, Weil EH, Van Kerrebroeck PE. Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. Brit. J. Urol. Int. 90(9), 840-845 (2002).
45. Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 49(3), 358-362 (1997).
46. Scheepens WA, Jongen MM, Nieman FH, de Bie RA, Weil EH, van Kerrebroeck PE. Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Urology 60(4), 598-602 (2002).
47. Bemelmans BL, Mundy AR, Craggs MD. Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur. Urol. 36(2), 81-91 (1999).
48. Dasgupta R, Wiseman OJ, Kitchen N, Fowler CJ. Long-term results of sacral neuromodulation for women with urinary retention. Brit. J. Urol. Int. 94(3), 335-357 (2004).